Walleye Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Walleye Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,732	Closed	-$1.37M	–	4552
2022 Q4	$1.37M	Sell	100,732 -59,043	-37%	-$822K	0.03%	795
2022 Q3	$2.21M	Buy	159,775 +55,967	+54%	+$831K	0.04%	499
2022 Q2	$1.49M	Sell	103,808 -20,516	-17%	-$356K	0.04%	464
2022 Q1	$2.81M	Sell	124,324 -75,691	-38%	-$1.47M	0.08%	273
2021 Q4	$3.76M	Buy	200,015 +129,967	+186%	+$3.47M	0.12%	184
2021 Q3	$2.3M	Sell	70,048 -26,051	-27%	-$972K	0.07%	202
2021 Q2	$4.1M	Buy	96,099 +11,765	+14%	+$460K	0.14%	105
2021 Q1	$3.23M	Buy	84,334 +13,803	+20%	+$588K	0.19%	89
2020 Q4	$3.09M	Buy	+70,531	New	+$2.65M	0.21%	77

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Walleye Capital's CSII Position: Q1 2023 in Review

Walleye Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 100,732 shares — an estimated $1.37M sold.

Walleye Capital first reported a position in CSII in Q4 2020 and held it in 9 quarters. The position peaked at $4.1M in Q2 2021. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Walleye Capital reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 100,732 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $1.37M.
Walleye Capital first reported a position in Cardiovascular Systems, Inc. in Q4 2020 and held it in 9 quarters.
Walleye Capital's Cardiovascular Systems, Inc. position peaked at $4.1M in Q2 2021.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.